BREAKING NEWS: Today, the US FDA approved our drug for the maintenance treatment of #COPD in adults, making it the first inhaled product with a novel mechanism of action for this indication in over 20 years. Learn more: https://bit.ly/4bnUSxt #FDAApproval
Congratulations to Verona and everyone involved in reaching this fantastic milestone!
Many Congratulations to the current team at Verona Pharma and indeed all my former collegaues who worked on this asset in the past. Proud to have been a part of its development!
Philippe, You are not forgotten. Congrats on this great achievement. You are always in our thoughts and prayers. Michael Tutcher is no longer the person we knew. He has dementia. We will visit you when we come to London. Give us your e-mail to keep in touch with much love. Shirley and Marlyn.
Congratulations 🎈 to you and all the patients who will greatly benefit from this amazing molecular 🎈🎈🎈🎈🎈🎈🎈🎈🫁🫁🫁🫁🫁🫁🫁🫁🫁🎈🎈
Congratulations to the entire company!!! Brilliant news!
Congrats Kavita Aggarwal, Amy Dixon, PharmD, Stephen Fu, and the whole Verona team!
Nice! Closing the gap in unmet needs is crucial for patients living with COPD, particularly with medications that serve dual purposes: acting as both a bronchodilator and a non-steroidal anti-inflammatory.
What a success! Well done all people who worked on this over the years and made it possible!
Fantastic news ! Treatments for previously intractable and degenerative lung conditions appear to approaching a golden age. Let's hope progress keeps accelerating in this field as it is in others....
Director, TEKH Consulting Limited
3moFantastic news . A long and sometimes torturous journey successfully navigated. Many congratulations to all the team and those who have been involved over many years of its development.